Libre by Abbott
Comparable Mobile App this size sell around 3.1x annual profit (1.1 to 3.5x, 14 comps).
- Developer
- Abbott Diabetes Care Inc
- Genre
- Medical
- Ratings
- 164,266
- Price
- Free
- Version
- 1.3.0
Off-market target. Not listed for sale, so there are no public financials. The play is to approach the owner directly.
About
Libre app[±] is a continuous glucose-monitoring (CGM) app that helps people living with diabetes track their glucose. Compatible with FreeStyle Libre 2 and 3 system sensors. Why Libre app: • Readings automatically update on your phone[±] every minute. • Insights, a tap away. Designed to easily find readings, trends, and settings. COMPATIBILITY Compatibility may vary between operating systems. Learn more about compatible phones and devices at https://www.freestyle.abbott/us-en/support.html. APP INFORMATION Libre app[±] is intended for measuring glucose levels in people with diabetes age 4+ when used with FreeStyle Libre 2 and FreeStyle Libre 3 sensors, and for people with diabetes age 2+ when used with FreeStyle Libre 2 Plus and FreeStyle Libre 3 Plus sensors. For more information, refer to the user’s manual, accessible in the app. Consult a healthcare professional to confirm if this product is right for you or if you have questions about how to use this product to make treatment decisions. ±. For information about device compatibility, see https://www.freestyle.abbott/us-en/support.html ǂ. Libre Assist is a feature within Libre app that uses generative artificial intelligence to provide information on how foods could impact your glucose levels. Generative artificial intelligence may not always be accurate, and it should not be used to make treatment decisions. ◊. Do not use the smartwatch app for treatment decisions. Follow the Libre app instructions on your smartphone. ø.
Traffic, trend, size, and valuation figures here are estimates, not verified by the seller. Always do your own diligence before reaching out or making an offer.